Previous close | 1.1000 |
Open | 12.5000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 370.00 |
Expiry date | 2023-06-16 |
Day's range | 1.1000 - 12.5000 |
Contract range | N/A |
Volume | |
Open interest | 122 |
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $308.47, marking a -1.88% move from the previous day.
BOSTON & ZUG, Switzerland, March 27, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex’s hypoimmune cell therapies for type 1 diabetes (T1D).
There's no guarantee that you'll be a millionaire retiree. But these stocks could improve your odds.